Lenovo Unveils Pioneering AI-Driven Devices at Lenovo Innovation World 2024

5.9.2024 17:00:00 CEST | Business Wire | Press release

Lenovo also announced that it has extended its partnership with Formula 1®

Lenovo™, a global leader in technology innovation, announced its latest advancements at Lenovo Innovation World 2024, unveiling a series of AI PC devices, including ThinkPad™, ThinkBook™, Yoga™, and IdeaPad™ laptops, designed to transform both enterprise and consumer user experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905372293/en/

(Photo: Business Wire)

AI PC Era

AI PCs are set to revolutionize computing as their relevance grows, with 60% of PCs shipped by 2027 anticipated to be AI-capable. Lenovo’s AI PCs are at the forefront of this transformation, leveraging natural interactions, personalized large language models, and advanced computing architectures. These innovations make computing more personal by tailoring experiences to individual users, more productive by enhancing workflow efficiency, and more protected by integrating robust security features into AI-driven systems.

"At Lenovo, we are committed to pushing the boundaries of innovation and bringing AI-powered technology to everyone. Our latest AI PCs, including the groundbreaking Aura Edition series, represent a significant leap forward in delivering highly personalized, productive, and protected computing experiences,” said Luca Rossi, President of Lenovo Intelligent Devices Group. “Through close collaboration with industry leaders, we are redefining what’s possible with AI, ensuring that our customers can harness the full potential of these transformative technologies to drive productivity, creativity, and growth in the AI era."

Powering Business Users in the AI Era

In the commercial segment for business users, Lenovo introduced the ThinkPad X1 Carbon Gen 13 Aura Edition, a cutting-edge business laptop co-developed with Intel. This device features Intel® Core™ Ultra technology, offering unparalleled AI capabilities and a user-centric design. The Lenovo Aura Edition series include innovative features such as Smart Modes, which intuitively adapt performance and AI capabilities to user activities, and Smart Share, enabling seamless AI-driven image sharing between devices. Smart Care provides 24/7 real-time support, ensuring users receive the assistance they need. With its advanced AI capabilities, the ThinkPad X1 Carbon Gen 13 Aura Edition redefines productivity, security, and user interaction in a lightweight, premium build.

Alongside it, Lenovo presented the ThinkPad T14s Gen 6 AMD and the ThinkBook 16 Gen 7+ powered by AMD Ryzen™ AI processors, showcasing exceptional multitasking, creative expression, and energy efficiency. Additionally, Lenovo revealed the ThinkBook 16 Gen 7, equipped with the Snapdragon® X Plus 8-core processor, bringing robust AI performance to small and medium-sized businesses.

Lenovo also announced AI PC Fast Start, a solution designed to help organizations swiftly transition to AI-ready devices, maximizing ROI through AI-powered advisory and simplified deployment. Backed by Lenovo's award-winning support, these services accelerate AI adoption and ensure seamless implementation.

Lenovo showcased the Lenovo Auto Twist AI PC, a proof-of-concept that redefines user interaction with intelligent automation and AI. This device features an industry-first auto-twist design, integrating AI-powered flexibility, smart interaction, and enhanced security to create a seamless and ergonomic computing experience.

Empowering Consumers with AI Technology

For consumers, Lenovo introduced several distinct laptops. The Lenovo Yoga Slim 7i Aura Edition (15”, 9), developed in collaboration with Intel, represents the pinnacle of premium design and innovative technology. This laptop includes the Lenovo Aura Edition range of features tailored to enhance user experience, including Smart Modes, Smart Share and Smart Care. Powered by Intel's Core Ultra processor with high-performance integrated graphics, and an optional 2.8K OLED touchscreen delivering stunning visuals, the laptop is designed for demanding tasks.

The LenovoYoga Pro 7 (14”, 9), powered by the AMD Ryzen AI 9 processor with 50 TOPS neural processing unit (NPU) performance, is tailored for content creators and professionals who demand powerful multitasking and creative capabilities. It comes equipped with Lenovo X Power features to improve performance and efficiency. The Yoga Pro 7 also features a 14.5” PureSight Pro OLED display with stunning color accuracy and sharpness, providing an immersive visual experience for design and media work.

The Lenovo IdeaPad Slim 5x (14”, 9) and IdeaPad 5x 2-in-1 (14”, 9) further expand Lenovo’s AI offerings for mainstream users, blending sleek design with powerful performance. These devices, powered by Snapdragon X Plus 8-core processors, offer enhanced AI-driven productivity and versatile form factors, making them suitable for a wide range of user needs.

Lenovo further expands its IdeaPad laptop portfolio with the IdeaPad Slim 5 15" and 13" models, both of which are powered by AMD Ryzen 7000 Series Processors. These laptops offer robust performance for multitasking and demanding applications, and feature high quality displays for creative work and media consumption. Both models boast sleek, ultra-thin, and light designs, making them ideal for professionals and students alike.

Lenovo also showcases the Lenovo Creator Zone, an AI-powered software suite with Stable Diffusion 3 model, that enables creators to use natural language and reference images to generate and edit visual content, streamlining the creative process. The suite is initially available on the Lenovo Yoga Pro 9i, with support for additional Lenovo Yoga devices to follow.

Global Retail Design Language

Lenovo’s product showcase illustrated its innovative new Global Retail Design Language, a strategic initiative designed to transform the customer experience across all physical retail formats. This new design language, shown through the tables in the showcase area at Lenovo Innovation World, accentuates a cohesive and immersive brand presence, ensuring uniformity and consistency in Lenovo's global retail operations.

Built on five core principles designed to echo Lenovo’s recognizable visual identity through a premium feel using natural and more sustainable materials that exhibit warm minimalism and emphasizes Lenovo’s ecosystem of innovative products. By transforming the customer journey with engaging environments, interactive touchpoints, and personalized service, Lenovo aims to create an inspiring and memorable experience for every customer who engage with Lenovo in retail locations.

Lenovo Becomes Global Partner of Formula 1^®

Lenovo is set to become Global Partner of Formula 1 starting in 2025, while Motorola will serve as Global Smartphone Partner. This multi-year renewal will see Lenovo continue to provide cutting-edge technology, including High-Performance Computing solutions, servers, and edge devices, to support F1’s operations both at the track and remotely. Lenovo will also be the title sponsor of two races per season and increase its trackside branding alongside Motorola. The partnership highlights Lenovo’s commitment to innovation and sustainability, with initiatives like Lenovo’s Asset Recovery Service contributing to F1’s sustainability goals. Together, Lenovo and F1 will explore next-generation technologies such as AI PCs, AI-enabled Motorola smartphones and AR/VR solutions, further enhancing the sport’s global reach and fan engagement.

Lenovo Innovation World 2024

For more information, visit Lenovo’s Innovation World homepage or reference the announcements below:

About Lenovo

Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905372293/en/

Contacts

Adrian Horne, adrianhorne@lenovo.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom